chartexchange

SBIO
ALPS Medical Breakthroughs ETF
stockNYSEETF

At CloseNov 18, 2026 3:59:46 PM EST
52.92USD-1.130%(-0.61)17,354
Loading…
Loading…
177.30M
HQ
CO, USA
Previous Close
$53.53
Beta
1.16
52-Week High
$70.85 2026-08-19
52-Week Low
$45.65 2025-11-21
SMA 50
$56.53
SMA 200
$57.23
Avg. Vol 10D
21,256
Avg. Vol 30D
26,846
Avg. Vol 90D
36,127
Relative Vol
0.65
3.35M
2.7000%
170
Dec 20, 2018 · $0.784
SBIO Profile

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

SBIO Performance
PeriodPriceDateChangeBeta
1W55.912026-11-12-5.34%1.384
1M52.112026-10-19+1.56%1.456
3M70.792026-08-19-25.24%1.340
6M50.922026-05-19+3.94%1.027
1Y46.592025-11-19+13.60%1.160
2Y36.892024-11-19+43.45%—
5Y44.972021-11-19+17.69%1.109
SBIO Stock Summary

ALPS Medical Breakthroughs ETF (NYSE:SBIO) stock price today is $52.93, and today's volume is 17,354. SBIO is down 1.130% today. The 30 day average volume is 26,846. SBIO market cap is $177.30M with 3.35M shares outstanding.